“When the Bug Cannot Be Killed”—The Rising Challenge of Antimicrobial Resistance
AbstractAntimicrobial resistance is a major global health issue that has the potential to reverse the substantial progress made against infectious diseases over the past several decades. We need strategic measures to deal with this challenge, including an intensification of public funding for research into anti-microbial agents and their alternatives, stricter mechanisms to minimize antimicrobial misuse within both clinical and non-clinical settings, and support for the development of country-level initiatives. Only with sustained, concerted, and coordinated global efforts are we likely to overcome the current and future challenges posed by these emerging “superbugs”. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Ofori-Asenso, R. “When the Bug Cannot Be Killed”—The Rising Challenge of Antimicrobial Resistance. Medicines 2017, 4, 40.
Ofori-Asenso R. “When the Bug Cannot Be Killed”—The Rising Challenge of Antimicrobial Resistance. Medicines. 2017; 4(2):40.Chicago/Turabian Style
Ofori-Asenso, Richard. 2017. "“When the Bug Cannot Be Killed”—The Rising Challenge of Antimicrobial Resistance." Medicines 4, no. 2: 40.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.